Year |
Citation |
Score |
2024 |
Kadota JL, Packel LJ, Mlowe M, Ulenga N, Mwenda N, Njau PF, Dow WH, Wang J, Sabasaba A, McCoy SI. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania. Trials. 25: 114. PMID 38336793 DOI: 10.1186/s13063-024-07960-x |
0.446 |
|
2023 |
Kadota JL, Packel LJ, Mlowe M, Ulenga N, Mwenda N, Njau PF, Dow WH, Wang J, Sabasaba A, McCoy SI. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania. Research Square. PMID 38196655 DOI: 10.21203/rs.3.rs-3315136/v1 |
0.386 |
|
2023 |
Wu EL, Christian B, Rivera AS, Fabian E, Macha I, Aris E, Mpangala S, Ulenga N, Mugusi F, Murphy RL, Hawkins CA. Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania. The Journal of Antimicrobial Chemotherapy. PMID 37935111 DOI: 10.1093/jac/dkad341 |
0.435 |
|
2023 |
Regan M, Muhihi A, Saleh A, Duggan CP, Ulenga N, Alwy Al-Beity FM, Aboud S, Fawzi WW, Manji KP, Sudfeld CR. Antenatal depression and adverse birth outcomes among pregnant women living with HIV in Dar es Salaam, Tanzania. Journal of Affective Disorders. 339: 82-88. PMID 37437720 DOI: 10.1016/j.jad.2023.07.047 |
0.314 |
|
2023 |
Perumal N, Saleh A, Muhihi A, McCoy D, Seiden J, Bakari M, Ndesangia V, Ulenga N, Sudfeld CR, Manji KP. School readiness among children born to women living with HIV in Dar es Salaam, Tanzania: a cohort study protocol. Bmj Paediatrics Open. 6. PMID 36645758 DOI: 10.1136/bmjpo-2022-001572 |
0.333 |
|
2022 |
Abioye AI, Sudfeld CR, Hughes MD, Aboud S, Muhihi A, Ulenga N, Nagu TJ, Wang M, Mugusi F, Fawzi WW. Iron status among HIV-infected adults during the first year of antiretroviral therapy in Tanzania. Hiv Medicine. PMID 36075691 DOI: 10.1111/hiv.13396 |
0.376 |
|
2022 |
Quinn MK, Williams PL, Muhihi A, Duggan CP, Ulenga N, Alwy Al-Beity FM, Perumal N, Aboud S, Fawzi WW, Manji KP, Sudfeld CR. Timing of antiretroviral therapy initiation and birth outcomes among pregnant women living with HIV in Tanzania. The Journal of Infectious Diseases. PMID 35678698 DOI: 10.1093/infdis/jiac224 |
0.399 |
|
2022 |
Muhihi A, Fawzi WW, Aboud S, Nagu TJ, Ulenga N, Wang M, Mugusi F, Sudfeld CR. Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression Among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial. The Journal of Nutrition. PMID 35460249 DOI: 10.1093/jn/nxac096 |
0.38 |
|
2022 |
Sudfeld CR, Manji KP, Muhihi A, Duggan CP, Aboud S, Alwy Al-Beity FM, Wang M, Zhang N, Ulenga N, Fawzi WW. Vitamin D3 supplementation during pregnancy and lactation for women living with HIV in Tanzania: A randomized controlled trial. Plos Medicine. 19: e1003973. PMID 35427363 DOI: 10.1371/journal.pmed.1003973 |
0.311 |
|
2022 |
Andersen CT, Duggan CP, Manji K, Seage GR, Spiegelman D, Perumal N, Ulenga N, Fawzi WW. Iron supplementation and paediatric HIV disease progression: a cohort study among children receiving routine HIV care in Dar es Salaam, Tanzania. International Journal of Epidemiology. PMID 35167662 DOI: 10.1093/ije/dyac017 |
0.401 |
|
2021 |
Lyatuu GW, Mwashemele SZ, Urrio R, Naburi H, Kashmir N, Machumi L, Kibao A, Sellah Z, Ulenga N, Orsini N, Biberfeld G, Kilewo C, Ekström AM. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study. The Lancet. Hiv. 8: e256-e265. PMID 33581776 DOI: 10.1016/S2352-3018(20)30308-8 |
0.415 |
|
2020 |
Fahey CA, Njau PF, Katabaro E, Mfaume RS, Ulenga N, Mwenda N, Bradshaw PT, Dow WH, Padian NS, Jewell NP, McCoy SI. Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial. The Lancet. Hiv. PMID 32891234 DOI: 10.1016/S2352-3018(20)30230-7 |
0.515 |
|
2020 |
Sudfeld CR, Mugusi F, Muhihi A, Aboud S, Nagu TJ, Ulenga N, Hong B, Wang M, Fawzi WW. Efficacy of vitamin D supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: a randomised, double-blind, placebo-controlled trial. The Lancet. Hiv. 7: e463-e471. PMID 32621874 DOI: 10.1016/S2352-3018(20)30108-9 |
0.379 |
|
2019 |
Barnhart DA, Harling G, Muya A, Ortblad KF, Mashasi I, Dambach P, Ulenga N, Mboggo E, Oldenburg CE, Bärnighausen TW, Spiegelman D. Structural, interpersonal, psychosocial, and behavioral risk factors for HIV acquisition among female bar workers in Dar es Salaam, Tanzania. Aids Care. 1-10. PMID 31079476 DOI: 10.1080/09540121.2019.1612018 |
0.519 |
|
2019 |
Harling G, Muya A, Ortblad KF, Mashasi I, Dambach P, Ulenga N, Barnhart D, Mboggo E, Oldenburg CE, Bärnighausen T, Spiegelman D. HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey. Bmj Open. 9: e023272. PMID 30898799 DOI: 10.1136/Bmjopen-2018-023272 |
0.498 |
|
2019 |
Christian B, Fabian E, Macha I, Mpangala S, Thio CL, Ulenga N, Mugusi F, Ammerman LR, Fawzi W, Green R, Murphy R, Hawkins C. Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy. Aids (London, England). 33: 465-473. PMID 30702515 DOI: 10.1097/Qad.0000000000002073 |
0.477 |
|
2018 |
Sungi SS, Ngaimisi E, Ulenga N, Sasi P, Mugusi S. Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania. Bmc Pharmacology & Toxicology. 19: 66. PMID 30352627 DOI: 10.1186/s40360-018-0258-6 |
0.305 |
|
2018 |
Sudfeld CR, Buchanan A, Ulenga N, Spiegelman D, Mtisi E, Hertzmark E, Muya AN, Sando D, Mungure E, Mizinduko M, Fawzi WW. Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania. Aids (London, England). PMID 30289815 DOI: 10.1097/Qad.0000000000002033 |
0.481 |
|
2018 |
Geldsetzer P, Francis JM, Sando D, Asmus G, Lema IA, Mboggo E, Koda H, Lwezaula S, Ambikapathi R, Fawzi W, Ulenga N, Bärnighausen T. Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania. Plos Medicine. 15: e1002659. PMID 30231024 DOI: 10.1371/Journal.Pmed.1002659 |
0.402 |
|
2018 |
Chaudhury S, Hertzmark E, Muya A, Sando D, Ulenga N, Machumi L, Spiegelman D, Fawzi WW. Equity of child and adolescent treatment, continuity of care and mortality, according to age and gender among enrollees in a large HIV programme in Tanzania. Journal of the International Aids Society. 21. PMID 29485735 DOI: 10.1002/Jia2.25070 |
0.389 |
|
2018 |
Kawai K, Hawkins CA, Hertzmark E, Francis JM, Sando D, Muya AN, Ulenga N, Fawzi WW. Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania. The American Journal of Tropical Medicine and Hygiene. PMID 29313475 DOI: 10.4269/Ajtmh.17-0568 |
0.512 |
|
2017 |
Sunguya BF, Ulenga NK, Siril H, Puryear S, Aris E, Mtisi E, Tarimo E, Urassa DP, Fawzi W, Mugusi F. High magnitude of under nutrition among HIV infected adults who have not started ART in Tanzania--a call to include nutrition care and treatment in the test and treat model. Bmc Nutrition. 3: 58. PMID 32153838 DOI: 10.1186/S40795-017-0180-0 |
0.524 |
|
2017 |
Njelekela M, Mpembeni R, Muhihi A, Ulenga N, Aris E, Kakoko D. Lipodystrophy among HIV-Infected Patients Attending Care and Treatment Clinics in Dar es Salaam. Aids Research and Treatment. 2017: 3896539. PMID 29158917 DOI: 10.1155/2017/3896539 |
0.534 |
|
2017 |
Hawkins C, Christian B, Fabian E, Macha I, Gawile C, Mpangala S, Ulenga N, Thio CL, Ammerman LR, Mugusi F, Fawzi W, Green R, Murphy R. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. Journal of Acquired Immune Deficiency Syndromes (1999). 76: 298-302. PMID 29016448 DOI: 10.1097/Qai.0000000000001491 |
0.499 |
|
2017 |
Hawkins C, Christian B, Fabian E, Macha I, Gawile C, Mpangala S, Ulenga N, Thio CL, Rose Ammerman L, Mugusi F, Fawzi W, Green R, Murphy R. HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28650402 DOI: 10.1097/QAI.0000000000001491 |
0.431 |
|
2017 |
Hawkins C, Hertzmark E, Spiegelman D, Muya A, Ulenga N, Kim S, Khudyakov P, Christian B, Sando D, Aris E, Fawzi W. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort. The Journal of Antimicrobial Chemotherapy. PMID 28387836 DOI: 10.1093/Jac/Dkx098 |
0.406 |
|
2017 |
Geldsetzer P, Francis JM, Ulenga N, Sando D, Lema IA, Mboggo E, Vaikath M, Koda H, Lwezaula S, Hu J, Noor RA, Olofin I, Larson E, Fawzi W, Bärnighausen T. The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania. Bmc Health Services Research. 17: 160. PMID 28228134 DOI: 10.1186/S12913-017-2032-7 |
0.334 |
|
2016 |
Barnhart D, Hertzmark E, Liu E, Mungure E, Muya AN, Sando D, Chalamilla G, Ulenga N, Bärnighausen T, Fawzi W, Spiegelman D. Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania. Contemporary Clinical Trials Communications. 4: 161-169. PMID 27766318 DOI: 10.1016/J.Conctc.2016.09.001 |
0.399 |
|
2016 |
Hawkins C, Ulenga N, Liu E, Aboud S, Mugusi F, Chalamilla G, Sando D, Aris E, Carpenter D, Fawzi W. HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults. The Journal of Antimicrobial Chemotherapy. PMID 27076106 DOI: 10.1093/Jac/Dkw051 |
0.532 |
|
2013 |
Ulenga N, Kanki PJ. HIV treatment scale-up in Africa: The impact of drug resistance Hiv/Aids Treatment in Resource Poor Countries: Public Health Challenges. 45-56. DOI: 10.1007/978-1-4614-4520-3_5 |
0.604 |
|
2012 |
Kanki P, Ulenga N, Chaplin B. AF4 HIV Drug Resistance in Nigeria, a Cost-Effective New Methodology Jaids Journal of Acquired Immune Deficiency Syndromes. 59: 28. DOI: 10.1097/01.Qai.0000413824.50049.A5 |
0.572 |
|
2008 |
Ulenga NK, Sarr AD, Hamel D, Sankale JL, Mboup S, Kanki PJ. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. Aids Research and Human Retroviruses. 24: 1285-90. PMID 18851679 DOI: 10.1089/Aid.2008.0072 |
0.579 |
|
2008 |
Ulenga NK, Sarr AD, Thakore-Meloni S, Sankalé JL, Eisen G, Kanki PJ. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. The Journal of Infectious Diseases. 198: 486-92. PMID 18598197 DOI: 10.1086/590212 |
0.548 |
|
Show low-probability matches. |